First In-human Study Update: Study Open for Enrolment

Imagion Biosystems is pleased to announce that Monash Health has been established as the first clinical site and is ready to commence enrolment of patients for the MagSense™ HER2 breast cancer Phase I first-in-human study.

Read the announcement.